Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers

OBJECTIVE: Although SLE disproportionately affects minority racial groups, they are significantly under-represented in clinical trials in the USA. This may lead to misleading conclusions in race-based subgroup analyses. We conducted focus groups to evaluate the perceptions of diverse patients with l...

Descripción completa

Detalles Bibliográficos
Autores principales: Arriens, Cristina, Aberle, Teresa, Carthen, Fredonna, Kamp, Stan, Thanou, Aikaterini, Chakravarty, Eliza, James, Judith A, Merrill, Joan T, Ogunsanya, Motolani E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Trials and Drug Discovery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073780/
https://www.ncbi.nlm.nih.gov/pubmed/32201595
http://dx.doi.org/10.1136/lupus-2019-000360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073780/
https://www.ncbi.nlm.nih.gov/pubmed/32201595
http://dx.doi.org/10.1136/lupus-2019-000360

Ejemplares similares